Kangmei Pharma | 600518 - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Akebia Therapeutics USD 160.86M 13.02M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Dianthus Therapeutics USD 34.39M 3.89M 2026-06
Genomma Lab Internacional MXN 9.39B 1.73B 2026-06
Hypermarcas BRL 3.43B 676.7M 2026-03
Ionis Pharmaceuticals USD 315.64M 401.36M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Jiangsu Hengrui CNY 5.64B 732.51M 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Moderna USD 2.53B 139M 2026-06
Organon & Co USD 2.62B 116M 2026-06
Revvity USD 1.28B 37.71M 2026-06
Sh Fosun Pharma CNY 36.58B 156.4M 2026-03
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Viatris USD 6.35B 464.5M 2026-06
Wuxi Apptec CNY 28.79B 9.75B 2026-06
Xeris Pharmaceuticals USD 189.57M 70.97M 2026-06
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03